Status:
COMPLETED
Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
Lead Sponsor:
GlaxoSmithKline
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Randomized, double-blind, parallel group, multicenter study of subjects with Stage 1 or 2 essential hypertension who are not at target blood pressure (\<140/90mmHg) at Baseline. Subjects will be rando...
Eligibility Criteria
Inclusion
- Male or female age 18-80 years; stage 1 or 2 hypertension currently receiving 0 or 1 antihypertensive medication; mean sitting systolic blood pressure \>/=140mmHg to \</=170mmHg, or mean sitting diastolic blood pressure \>/=90 to \</=105mmHg. Subjects taking one hypertensive medication had their medication withdrawn and entered a wash-out phase prior to randomization.
Exclusion
- Subject taking two or more antihypertensive medications, known contraindication to angiotensin-converting enzyme (ACE) inhibitors or alpha- or beta-blocker therapy, subject has Type 1 or Type 2 diabetes
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT00624065
Start Date
March 1 2008
End Date
August 1 2008
Last Update
December 28 2016
Active Locations (76)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Mobile, Alabama, United States, 36617
2
GSK Investigational Site
Chandler, Arizona, United States, 77030
3
GSK Investigational Site
Glendale, Arizona, United States, 85308
4
GSK Investigational Site
Goodyear, Arizona, United States, 85395